This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CEO Alex Gorsky Elected Chairman Of Johnson & Johnson; Bill Weldon To Step Down After 41-year Career At Johnson & Johnson

NEW BRUNSWICK, N.J., Nov. 30, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has elected Alex Gorsky Chairman, Board of Directors of Johnson & Johnson.  Mr. Gorsky will assume the Chairman title and additional leadership responsibilities for the global health care company on Dec. 28, 2012; Mr. Gorsky was appointed Chief Executive Officer of Johnson & Johnson in April 2012.  Current Chairman Bill Weldon will step down as Chairman on Dec. 28, 2012, and announced plans to retire in the first quarter of 2013, after a brief transitional period.

"I am truly honored to succeed Bill Weldon as Chairman of Johnson & Johnson," said Mr. Gorsky.  "Bill's leadership and contributions to Johnson & Johnson over a 41-year career leave us well-positioned to continue addressing the world's most prevalent diseases and unmet needs in health care.  Our financial strength, global reach, and innovations that help people live longer, healthier lives are a proud legacy for Bill and a strong foundation for the future of Johnson & Johnson."

"Throughout his career, leaders from the public and private sector, from business and government, have all turned to Bill for his views on health care and corporate matters – a tribute to his leadership of Johnson & Johnson and his clear thinking on a broad range of complex issues and policies," said Mr. Gorsky.  "His advocacy for patients and his strong sense of corporate values will have a lasting influence on our company and our industry."

"Serving as Chairman and CEO of Johnson & Johnson has been a privilege, and I am confident in Alex's ability to lead the people of Johnson & Johnson to even greater achievements," said Weldon.  "I would like to thank the people of Johnson & Johnson for all their commitment and dedication to the patients and customers they serve.  They bring to life the hope and promise of better treatments, cures, health and well-being for those who use our products.  It has been an honor to work with them."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs